Does ELTROMBOPAG OLAMINE Cause Product dose omission issue? 371 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 371 reports of Product dose omission issue have been filed in association with ELTROMBOPAG OLAMINE (ELTROMBOPAG). This represents 2.3% of all adverse event reports for ELTROMBOPAG OLAMINE.
371
Reports of Product dose omission issue with ELTROMBOPAG OLAMINE
2.3%
of all ELTROMBOPAG OLAMINE reports
7
Deaths
122
Hospitalizations
How Dangerous Is Product dose omission issue From ELTROMBOPAG OLAMINE?
Of the 371 reports, 7 (1.9%) resulted in death, 122 (32.9%) required hospitalization, and 40 (10.8%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG OLAMINE. However, 371 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG OLAMINE Cause?
Platelet count decreased (3,419)
Death (2,797)
Drug ineffective (1,117)
Platelet count increased (980)
Fatigue (868)
Headache (750)
Nausea (584)
Diarrhoea (558)
Product use in unapproved indication (545)
Malaise (516)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ELTROMBOPAG OLAMINE Alternatives Have Lower Product dose omission issue Risk?
ELTROMBOPAG OLAMINE vs ELUXADOLINE
ELTROMBOPAG OLAMINE vs ELVITEGRAVIR
ELTROMBOPAG OLAMINE vs EMAPALUMAB
ELTROMBOPAG OLAMINE vs EMAPALUMAB-LZSG
ELTROMBOPAG OLAMINE vs EMEND